Report Categories
View AllRecent Articles
View All
KALV KalVista Pharmaceuticals posts 291 Q4 2025 EPS surprise shares dip marginally in daily trading
SYBT Stock tops first quarter 2026 EPS estimates shares gain 209 percent on upbeat investor reaction
CMBT CMBTECH NV reports steep Q4 2025 EPS miss but shares rise 379 percent on upbeat investor sentiment
What separates LENSAR LNSR from the pack Slight Loss 20260508